Clinical manifestations of mitochondrial disease on fetal development Antenatal manifestations reported in MDs include Fetal Growth Restriction (FGR), Subependymal pseudocysts (SEPC), Chronic intestinal pseudo-obstruction (CIPO), Cardiomyopathy (CM), reduced movement and skin oedema
NiuYNiuHChiLLiPDuJWangXet al
For each micronutrient, the following keywords were used: ((nutrient) OR (nutrient deficiency)) AND ((cancer prevention) OR (cancer protection)) ((nutrient) OR (nutrient deficiency)) AND ((protective effect) AND ((cancer) OR (oncology))) ((nutrient) OR (nutrient deficiency)) AND ((cancer risk) OR (cancer incidence) OR (cancer development)) ((nutrient) OR (nutrient deficiency)) AND (supplementation) AND ((cancer) OR (oncology)) ((nutrient) OR (nutrient deficiency)) AND (((toxicity) OR (toxicities) OR (adverse events) OR (adverse effects)) AND ((cancer) OR (oncology))) Only scientific articles (international guidelines, clinical trials, meta-analyses, systematic and narrative reviews) published until January 2025 and written in English were included
Additional options selected to get a best-fitting model included 1) times of measurement were set as equally spaced, and 2) allowance of unequal variances across time
TMT-labeled peptides (~4.5 mg per set) were fractionated by bRPLC on an Agilent Zorbax Extend-C18 column (4.6 250 mm, 3.5 m) using ammonium formate (pH 10)acetonitrile gradients, concatenated into 24 fractions
BMC Cancer 16 , 738 (2016)
